Filter News
Area of Research
- (-) Supercomputing (33)
- Biology and Environment (35)
- Clean Energy (30)
- Computational Engineering (1)
- Computer Science (1)
- Energy Frontier Research Centers (1)
- Fusion and Fission (6)
- Isotope Development and Production (1)
- Isotopes (15)
- Materials (74)
- Materials Characterization (1)
- Materials for Computing (7)
- Materials Under Extremes (1)
- National Security (4)
- Neutron Science (49)
- Nuclear Science and Technology (4)
News Type
News Topics
- (-) Biomedical (5)
- (-) High-Performance Computing (14)
- (-) Isotopes (1)
- (-) Materials Science (6)
- (-) Microscopy (5)
- (-) Molten Salt (1)
- (-) Nanotechnology (5)
- (-) Neutron Science (7)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (12)
- Big Data (2)
- Bioenergy (6)
- Biology (4)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (3)
- Climate Change (5)
- Computer Science (34)
- Coronavirus (5)
- Cybersecurity (6)
- Decarbonization (1)
- Energy Storage (5)
- Environment (5)
- Exascale Computing (8)
- Frontier (13)
- Grid (3)
- Machine Learning (5)
- Materials (9)
- National Security (5)
- Nuclear Energy (1)
- Partnerships (1)
- Physics (4)
- Quantum Computing (5)
- Quantum Science (10)
- Security (4)
- Simulation (2)
- Space Exploration (1)
- Summit (14)
- Sustainable Energy (5)
- Transportation (2)
Media Contacts
Using the Titan supercomputer and the Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory, scientists have created the most accurate 3D model yet of an intrinsically disordered protein, revealing the ensemble of its atomic-level structures.
OAK RIDGE, Tenn., May 7, 2019—Energy Secretary Rick Perry, Congressman Chuck Fleischmann and lab officials today broke ground on a multipurpose research facility that will provide state-of-the-art laboratory space
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.